Essec\Faculty\Model\Contribution {#2216
  #_index: "academ_contributions"
  #_id: "15001"
  #_source: array:26 [
    "id" => "15001"
    "slug" => "15001-reduced-rate-of-hospitalizations-for-acute-diabetes-events-before-and-after-freestyle-libre-system-initiation-in-some-people-with-type-2-diabetes-on-insulin-secretagogue-oral-drug-therapy-withou"
    "yearMonth" => "2024-12"
    "year" => "2024"
    "title" => "Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre® System Initiation in Some People With Type 2 Diabetes on Insulin-Secretagogue Oral Drug Therapy Without Insulin in France"
    "description" => "RIVELINE, J.P., LEVRAT-GUILLEN, F., DETOURNAY, B., VICAUT, E., PUYOU DE POUVOURVILLE, G., EMERY, C. et GUERCI, B. (2024). Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre® System Initiation in Some People With Type 2 Diabetes on Insulin-Secretagogue Oral Drug Therapy Without Insulin in France. <i>Diabetes Technology & Therapeutics</i>, 26(12), pp. 932-938."
    "authors" => array:7 [
      0 => array:3 [
        "name" => "PUYOU DE POUVOURVILLE Gérard"
        "bid" => "B00072308"
        "slug" => "de-pouvourville-gerard"
      ]
      1 => array:1 [
        "name" => "Riveline Jean-Pierre"
      ]
      2 => array:1 [
        "name" => "Levrat-Guillen Fleur"
      ]
      3 => array:1 [
        "name" => "Detournay Bruno"
      ]
      4 => array:1 [
        "name" => "Vicaut Eric"
      ]
      5 => array:1 [
        "name" => "Emery Corinne"
      ]
      6 => array:1 [
        "name" => "Guerci Bruno"
      ]
    ]
    "ouvrage" => ""
    "keywords" => array:7 [
      0 => "FreeStyle Libre"
      1 => "acute diabetes events"
      2 => "continuous glucose monitoring"
      3 => "flash glucose monitoring"
      4 => "insulin-secretagogues"
      5 => "noninsulin therapy"
      6 => "type 2 diabetes"
    ]
    "updatedAt" => "2025-03-24 15:52:27"
    "publicationUrl" => "https://doi.org/10.1089/dia.2024.0171"
    "publicationInfo" => array:3 [
      "pages" => "932-938"
      "volume" => "26"
      "number" => "12"
    ]
    "type" => array:2 [
      "fr" => "Articles"
      "en" => "Journal articles"
    ]
    "support_type" => array:2 [
      "fr" => "Revue scientifique"
      "en" => "Scientific journal"
    ]
    "countries" => array:2 [
      "fr" => "États-Unis"
      "en" => "United States of America"
    ]
    "abstract" => array:2 [
      "fr" => "Glycemic management in people with type 2 diabetes mellitus (T2DM) on insulin-secretagogue regimens without insulin is of importance, as this group still represents a significant proportion of patients. Risks for acute diabetes events (ADEs), including diabetic ketoacidosis (DKA) or hypoglycemia, using insulin-secretagogue drugs are well established. Few studies have suggested that continuous glucose monitoring (CGM) could be useful for monitoring glucose dynamics associated with the use of such therapies. To document this point an exploratory analysis was conducted in a group of individuals with noninsulin treated T2DM in France who are managed with oral insulin-secretagogues and initiating the FreeStyle Libre® system (FSL). Methods: A retrospective study of the French national SNDS reimbursement claims database (≈66 million French people) was conducted to identify people with T2DM on oral insulin-secretagogues and receiving a first reimbursement of FSL between August 1, 2017 and December 31, 2018. The analysis included data for the 12 months before and up to 24 months after FSL initiation. Hospitalizations for diabetes-related acute events were identified using ICD-10 codes as main or related diagnosis, for: hypoglycemic events; DKA events; comas; and hyperglycemia-related admissions."
      "en" => "Glycemic management in people with type 2 diabetes mellitus (T2DM) on insulin-secretagogue regimens without insulin is of importance, as this group still represents a significant proportion of patients. Risks for acute diabetes events (ADEs), including diabetic ketoacidosis (DKA) or hypoglycemia, using insulin-secretagogue drugs are well established. Few studies have suggested that continuous glucose monitoring (CGM) could be useful for monitoring glucose dynamics associated with the use of such therapies. To document this point an exploratory analysis was conducted in a group of individuals with noninsulin treated T2DM in France who are managed with oral insulin-secretagogues and initiating the FreeStyle Libre® system (FSL). Methods: A retrospective study of the French national SNDS reimbursement claims database (≈66 million French people) was conducted to identify people with T2DM on oral insulin-secretagogues and receiving a first reimbursement of FSL between August 1, 2017 and December 31, 2018. The analysis included data for the 12 months before and up to 24 months after FSL initiation. Hospitalizations for diabetes-related acute events were identified using ICD-10 codes as main or related diagnosis, for: hypoglycemic events; DKA events; comas; and hyperglycemia-related admissions."
    ]
    "authors_fields" => array:2 [
      "fr" => "Management"
      "en" => "Management"
    ]
    "indexedAt" => "2026-02-19T06:21:46.000Z"
    "docTitle" => "Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre® System Initiation in Some People With Type 2 Diabetes on Insulin-Secretagogue Oral Drug Therapy Without Insulin in France"
    "docSurtitle" => "Journal articles"
    "authorNames" => "<a href="/cv/de-pouvourville-gerard">PUYOU DE POUVOURVILLE Gérard</a>, Riveline Jean-Pierre, Levrat-Guillen Fleur, Detournay Bruno, Vicaut Eric, Emery Corinne, Guerci Bruno"
    "docDescription" => "<span class="document-property-authors">PUYOU DE POUVOURVILLE Gérard, Riveline Jean-Pierre, Levrat-Guillen Fleur, Detournay Bruno, Vicaut Eric, Emery Corinne, Guerci Bruno</span><br><span class="document-property-authors_fields">Management</span> | <span class="document-property-year">2024</span>"
    "keywordList" => "<a href="#">FreeStyle Libre</a>, <a href="#">acute diabetes events</a>, <a href="#">continuous glucose monitoring</a>, <a href="#">flash glucose monitoring</a>, <a href="#">insulin-secretagogues</a>, <a href="#">noninsulin therapy</a>, <a href="#">type 2 diabetes</a>"
    "docPreview" => "<b>Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre® System Initiation in Some People With Type 2 Diabetes on Insulin-Secretagogue Oral Drug Therapy Without Insulin in France</b><br><span>2024-12 | Journal articles </span>"
    "docType" => "research"
    "publicationLink" => "<a href="https://doi.org/10.1089/dia.2024.0171" target="_blank">Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre® System Initiation in Some People With Type 2 Diabetes on Insulin-Secretagogue Oral Drug Therapy Without Insulin in France</a>"
  ]
  +lang: "en"
  +"_score": 8.628305
  +"_ignored": array:3 [
    0 => "abstract.en.keyword"
    1 => "abstract.fr.keyword"
    2 => "description.keyword"
  ]
  +"parent": null
}